AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...
(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...
Navigantis Inc. recently announced the first successful neurovascular clinical cases performed with its Vasco interventional ro ...
Q2 2025 Earnings Call Transcript January 8, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.04, ...
Pulmonary angiography is a test that studies blood flow in your lungs. Its purpose is to find problems such as pulmonary embolisms (blood clots in your lungs), stenosis (narrowed blood vessels), or ...
Our study assessed the clinical value of single‐vessel, multivessel, and 3‐vessel computational angiography–derived fractional flow reserve (caFFR) measurement in patients with nonobstructive coronary ...
Background Despite successful recanalization via mechanical thrombectomy (MT), only half of acute ischemic ... affect functional outcomes using quantitative digital subtraction angiography (Q-DSA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback